PLI PLUS 2.0 is now available – click
here
to test drive the new platform.
Skip to main content
Create Account
Training Center
Contact Us
Questions? Comments?
Contact us.
Email:
PLUS@pli.edu
Phone:
877.900.5291
PLI.edu
SIGN IN
Search
Browse
All Content
Books
- Answer Books
- Course Handbooks
- Journals
- Insights
- Treatises
Forms & Checklists
Transcripts
My Bookshelf
My History
< Back To Results
1 in 13785 results
Previous Result
Next Result
Patent Law Institute (2nd Annual)
Chair(s):
Scott M. Alter
Practice Area:
Intellectual property,
Litigation,
Patent applications,
Patent claims,
Patent litigation,
Patents
Published:
Jan 2008
i
Other versions can be found in the
Related Items
tab.
ISBN:
9781402409974
PLI Item #:
14506
CHB Spine #:
G922, G923
This version is not current.
Click here for the most recent version.
Search
Email
Print
Add To Bookshelf
Permalink
Table of Contents
Related Items
Select All
Front Matter
Table of Contents Vol. 1
Table of Contents Vol. 2
Chapter 1. Day One 9:15—Recent Court Decisions and Their Practice Impact
Chapter 2. Recent Court Decisions and Their Practice Impact
Chapter 3. PowerPoint Slides: KSR v. Teleflex S. CT. 4/07
Chapter 4. Living Under the Continuing Application and Claim Limitation Rules: Strategies for Success
Chapter 5. Developing and Maintaining Patent Portfolios in View of Recent U.S. Case Law and U.S. PTO Rules Changes
Chapter 6. Litigating in the Eastern District of Texas
Chapter 7. Prosecution: PTO Rules Breakout I—Continuations/Representative Claim Rule Packages
Chapter 8. Final Rule on Claims and Continuations Rules That May Evolve After the GSK Injunction
Chapter 9. 37 CFR Part 1 Changes to Practice for Continued Examination Filings, Patent Applications Containing Patentably Indistinct Claims, and Examination of Claims in Patent Applications; Final Rule, Federal Register, Department of Commerce, August 21, 2007
Chapter 10. Attorney Opinions, Waiver, and the New Law of Willful Infringement in Light of In Re Seagate
Chapter 11. Exculpatory Patent Opinions and Special Problems Regarding Waiver of Privilege
Chapter 12. Practical Guidelines for Managing eDiscovery Without Breaking the Bank
Chapter 13. Practical Guidelines for Managing eDiscovery Without Breaking the Bank
Chapter 14. Changes to Information Disclosure Statement (IDS) Requirements Notice of Proposed Rulemaking (NPR)
Chapter 15. Notice of Proposed Rule Making Affecting Claims That Recite Alternatives
Chapter 16. 37 CFR Part 1 Changes to Information Disclosure Statement Requirements and Other Related Matters, Federal Register, Department of Commerce, July 10, 2006
Chapter 17. 37 CFR Part 1 Examination of Patent Applications That Include Claims Containing Alternative Language, Federal Register, Department of Commerce, August 10, 2007
Chapter 18. Negotiating with Companies in Asia
Chapter 19. What Lawyers Need to Know About the Business of Selling and Licensing Patents
Chapter 20. Recent Developments in Pharmaceutical and Biotechnology Litigation
Chapter 21. FDA Activities That Can and Cannot Give Rise to Patent Litigation in the Federal District Courts and the International Trade Commission
Chapter 22. Patent Reform Act (110th Congress)
Chapter 23. U.S. Department of Justice Guidance Regarding Ex Ante Patent Licensing Policies of Standard-Setting Organizations
Chapter 24. Current “Patent-Antitrust Interface” Issues and Their Potential Effect on Patent Litigation
Chapter 25. 2007 Supreme Court Antitrust Developments
Chapter 26. PTO Biotech/Pharma Trends—News to Report
Chapter 27. Developments in Patent Licensing
Chapter 28. Tightening the Reins: The Implications of Recent Federal Circuit Decisions on the Patentability of Business Methods Under 35 U.S.C. § 101
Chapter 29. The Business Method Patent 360: Have They Come Full Circle (or Did they Never Change)?
Chapter 30. The New Age of Electronic Patent Filing from A-Z: The Patent Side Goes Paperless
Chapter 31. The Changing Landscape of Obviousness in the Wake of KSR
Chapter 32. Prosecution Ethics
Chapter 33. Ethical Obligations of Patent Practitioners: Do You Know the Rules?
Chapter 34. Valuing Patents and Other Intellectual Property in Licensing Transactions
Chapter 35. PCT Infringement Issues
Chapter 36. Inequitable Conduct—The Widening “Plague”/Continues to Spread
Chapter 37. Amgen, Inc. v. F. Hoffmann-La Roche LTD., Roche Diagnostics GmbH and Hoffmann-La Roche, Inc., Daily Transcript of the Evidence and Jury Instructions, CIV. No. 05-12237-WGY (October 17, 2007
Chapter 38. Managing the Runaway Patent Case, ABTL Report, Volume 12, No. 3, Summer 2003
Index Chapters 1-14
Index Chapters 15-38
About Us